- Home
- RPD vs ETON Comparison
RPD vs ETON Comparison
Compare RPD & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPD | ETON |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 746.5M | 872.7M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RPD | ETON |
|---|---|---|
| Price | $10.18 | $45.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 23 | 3 |
| Target Price | $15.05 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 2.9M | 523.9K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.02 | ★ 0.05 |
| Revenue | ★ $685,083,000.00 | $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $0.54 | $47.23 |
| P/E Ratio | ★ $482.50 | $928.40 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $4.97 | $13.99 |
| 52 Week High | $21.78 | $50.18 |
Technical Indicators
Market Signals| Indicator | RPD | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 53.91 | 60.91 |
| Support Level | $5.68 | $15.77 |
| Resistance Level | $13.75 | N/A |
| Average True Range (ATR) | 0.78 | 2.78 |
| MACD | -0.27 | 0.24 |
| Stochastic Oscillator | 30.05 | 60.28 |
Price Performance
Historical ComparisonAbout RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.